日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy

带电粒子和常规放射疗法：作为免疫疗法合作伙伴的当前意义

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13061468
Marcus, Damiënne; Lieverse, Relinde I Y; Klein, Carmen; Abdollahi, Amir; Lambin, Philippe; Dubois, Ludwig J; Yaromina, Ala
免疫/内分泌
发表日期：2021
文献求助 收藏

Hypoxia PET Imaging with [18F]-HX4-A Promising Next-Generation Tracer

利用[18F]-HX4-A进行低氧PET成像：一种极具前景的下一代示踪剂

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers12051322
Sanduleanu, Sebastian; Wiel, Alexander M A van der; Lieverse, Relinde I Y; Marcus, Damiënne; Ibrahim, Abdalla; Primakov, Sergey; Wu, Guangyao; Theys, Jan; Yaromina, Ala; Dubois, Ludwig J; Lambin, Philippe
发表日期：2020
文献求助 收藏

Radiomics: from qualitative to quantitative imaging

放射组学：从定性成像到定量成像

期刊:British Journal of Radiology
影响因子:3.4
doi:10.1259/bjr.20190948
Rogers, William; Thulasi Seetha, Sithin; Refaee, Turkey A G; Lieverse, Relinde I Y; Granzier, Renée W Y; Ibrahim, Abdalla; Keek, Simon A; Sanduleanu, Sebastian; Primakov, Sergey P; Beuque, Manon P L; Marcus, Damiënne; van der Wiel, Alexander M A; Zerka, Fadila; Oberije, Cary J G; van Timmeren, Janita E; Woodruff, Henry C; Lambin, Philippe
发表日期：2020
文献求助 收藏

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

立体定向消融放射治疗（SABR）联合免疫疗法（L19-IL2）与标准疗法治疗IV期非小细胞肺癌患者的疗效比较：一项多中心、随机、对照、开放标签的II期临床试验（ImmunoSABR）。

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-020-07055-1
Lieverse, Relinde I Y; Van Limbergen, Evert J; Oberije, Cary J G; Troost, Esther G C; Hadrup, Sine R; Dingemans, Anne-Marie C; Hendriks, Lizza E L; Eckert, Franziska; Hiley, Crispin; Dooms, Christophe; Lievens, Yolande; de Jong, Monique C; Bussink, Johan; Geets, Xavier; Valentini, Vincenzo; Elia, Giuliano; Neri, Dario; Billiet, Charlotte; Abdollahi, Amir; Pasquier, David; Boisselier, Pierre; Yaromina, Ala; De Ruysscher, Dirk; Dubois, Ludwig J; Lambin, Philippe
肺癌
肿瘤
IL2
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2020
文献求助 收藏

Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy

淋巴细胞保护性放射疗法：放射疗法与免疫疗法联合应用时保护富含淋巴细胞器官的原理

期刊:Seminars in Radiation Oncology
影响因子:3.2
doi:10.1016/j.semradonc.2019.12.003
Lambin, Philippe; Lieverse, Relinde I Y; Eckert, Franziska; Marcus, Damiënne; Oberije, Cary; van der Wiel, Alexander M A; Guha, Chandan; Dubois, Ludwig J; Deasy, Joseph O
细胞生物学
免疫/内分泌
发表日期：2020
文献求助 收藏